HbA1c ReductionSelf-monitoring of blood glucose

Clinical evidence dossier

Self-monitoring of blood glucose

HbA1c

Evidence signal

Evidence signal

Strong

This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.

Evidence snapshot

Authoritative support records
4
Supporting studies available for review
4
Randomized trials
4
Reported effects
12

Clinical conclusion

Self-monitoring of blood glucose shows a moderate positive evidence signal for improving HbA1c across the studied comparisons.

The conclusion and evidence-signal classification are distinct authoritative fields and are reproduced as published.

Observed effects

Observed study estimates; not a pooled treatment effect.

Change from baseline

Absolute change

−0.7% to 0%

7 eligible estimates12–12 weeksObserved median: −0.67%

Change from baseline

Mean difference

−0.44% to 0.08%

5 eligible estimates12–26 weeksObserved median: −0.24%

Evidence composition

Non-randomized studies
0
Other designs
0
Unresolved designs
0
Magnitude-eligible effects
12

Consistency

Consistency classification

Mixed

Positive
1
No effect
0
Mixed
2
Negative
1

Population and applicability

Structured population data were available for 4 of 4 supporting studies. Diabetes type was heterogeneous: 2 studies with type 2 diabetes, 1 studies with type 1 diabetes. 3 studies described adult participants.

This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.

View reported population descriptions

These descriptions are reported across the supporting studies; they are not a single synthesized population.

  • Participants residing in India.
  • Adults with non-insulin treated type 2 diabetes.
  • Patients seeking to reduce the frequency of blood glucose monitoring.
  • Adults with type 2 diabetes
  • Individuals seeking to improve blood glucose control
  • Adults with insulin-treated diabetes
  • Patients seeking improved glucose management strategies

Limitations

  • Upstream consistency scoring indicates mixed findings across the evidence.
  • Evidence uses heterogeneous comparison contexts: active_comparator, usual_care.
  • 1 study contains conflicting p-value and significance fields; those significance claims are suppressed.

Supporting evidence

Inspect the authoritative studies and omitted support records for this dossier.

View supporting evidence